Close Menu

Applied Biocode

Hologic will use Applied BioCode's technology to create multiplexed nucleic acid-based tests aimed at the agricultural market, Applied BioCode said this week.

NEW YORK (GenomeWeb News) – Hologic will use Applied BioCode's technology to create multiplexed nucleic acid-based tests aimed at the agricultural market, Applied BioCode said today.

Under the agreement, EraGen receives access to Applied BioCode's barcoded magnetic bead technology and CE-Marked BioCode-1000 system, which EraGen will couple with its MultiCode-PLx assays for analyzing nucleic acid targets in infectious disease and genetic testing.

Applied BioCode's president said in a statement that the combination his firm's technology with EraGen's patented chemistry is expected to result in a "powerful testing platform for clinical laboratories."

The two affiliated firms, which recently announced receiving a $2.8 million NIH grant, are building out the MDx technology with an eye initially on MRSA and respiratory infectious diseases.

The two firms will use the grant to further develop Applied BioCode's Barcoded Magnetic Beads technology, which the company said can improve throughput while reducing the cost of diagnostic testing.

Following the dissolution last year of a longstanding relationship with Luminex, EraGen is once again eyeing the IVD market for its multiplex PCR assay reagents by partnering with other companies offering bead-based detection systems.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.